2025年11月7日，长药控股公告收到证监会下发的《立案告知书》，因公司涉嫌定期报告等财务数据虚 假记载，根据《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。 2024年4月30日，长药控股发布关于公司存在资金占用、违规担保暨公司股票可能被实施其他风险警示 的风险提示性公告，称公司2023年度财务报告审计机构中审亚太会计师事务所（特殊普通合伙）对公司 出具的带强调事项段和持续经营重大不确定性段落的无保留意见审计报告。 长江医药控股股份有限公司自查中发现，罗明及其实际控制的湖北长江大药房连锁有限公司因资金占用 导致公司下属子公司、长江星及其下属子公司与相关往来单位账实不符。截至报告期末，公司存在资金 占用179，662，019.54元，占公司最近一期经审计归母净资产的92.08%。公司将通过关联方债权债务转 让方式全部清偿关联方占用的资金。 专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为，根据前期投资者胜诉判决， 在2019年3月30日到2024年4月30日之间买入长药控股股票，并且在2024年4月30日后卖出或继续持有股 票的投资者，目前还可发起索赔。（长药控股维权入口） （本文由上海 ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 上海久诚律师事务所股票索赔律师许峰提示，长药控股（300391）虚假陈述引发的投资者索赔案还在持 续推进中。长药控股投资者索赔案已有投资者胜诉先例，目前还可继续发起索赔。（许峰律师专栏） 许峰律师代理的长药控股投资者索赔案已向武汉市中级人民法院提交立案，目前正在等待法院的下一步 安排，律师团队同步还在继续推进后续案件的立案工作，还在继续接受其他投资者的索赔委托。 2025年11月7日，长药控股公告收到证监会下发的《立案告知书》，因公司涉嫌定期报告等财务数据虚 假记载，根据《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。 2024年4月30日，长药控股发布关于公司存在资金占用、违规担保暨公司股票可能被实施其他风险警示 的风险提示性公告，称公司2023年度财务报告审计机构中审亚太会计师事务所（特殊普通合伙）对公司 出具的带强调事项段和持续经营重大不确定性段落的无保留意见审计报告。 长江医药控 ...

清越科技（688496）实控人撤回了股份回购提议。 12月12日晚，清越科技公告，公司董事长、总经理、实际控制人高裕弟基于公司目前正处于被立案调查 这一情况，为主动维护投资者合法权益，决定撤回股份回购提议。 今年10月31日，清越科技公告收到证监会出具的《立案告知书》，因公司涉嫌定期报告等财务数据虚假 记载，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对 公司立案。 公告披露后，清越科技于11月3日跌停，11月4日继续大跌。 12月12日，清越科技在公告中披露，高裕弟决定撤回股份回购提议的同时，向公司董事会提交了《关于 撤回股份回购提议并自愿承担未来上市公司一定范围民事赔偿额的承诺》。 清越科技表示，结合《中华人民共和国证券法》《最高人民法院关于审理证券市场虚假陈述侵权民事赔 偿案件的若干规定》等法律法规及司法解释，公司存在因定期报告等财务数据虚假记载而被投资者提起 民事诉讼、进而产生民事赔偿责任的风险。 高裕弟承诺并自愿承担未来上市公司可能产生的一定范围的民事赔偿额。若公司因前述立案调查涉及的 信息披露违规行为被投资者提起民事诉讼的赔偿要求，且被人民法院判决确定承担民事 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 若后续经中国证监会行政处罚认定的事实，触及《上海证券交易所科创板股票上市规则》规定的重大违 法强制退市情形，公司股票将被实施重大违法强制退市。截至本公告披露日，中国证监会的调查尚在进 行中，公司尚未收到就上述立案事项的结论性意见或决定。 苏州清越光电科技股份有限公司（以下简称"公司"）于2025年11月1日在上海证券交易所网站 （www.sse.com.cn）披露了《清越科技关于公司收到中国证券监督管理委员会立案告知书暨风险提示的 公告》，因公司涉嫌定期报告等财务数据虚假记载，根据《中华人民共和国证券法》《中华人民共和国 行政处罚法》等法律法规，中国证监会决定对公司立案。 目前，公司各项经营管理、业务及财务状况均正常。针对本次立案事项，公司高度重视，将积极配合中 国证监会调查，并严格按照相关法律法规要求履行信息披露义务，每月披露1次风险性提示公告，说明 立案调查进展情况。 公司指定信息披露媒体为上海证券交易所网站（www.sse.com.cn）和《中国证券报》《上海证券报》 《证券时报》《证券日报》《经济参考报》，公司相关信息均以在上述指定媒体披露的公告为准。 ...

Core Points - *ST Changyao (300391.SZ) experienced a decline of 9.34%, closing at 2.33 yuan, with a total market capitalization of 816.3 million yuan [1] - The company received a "Notice of Investigation" from the China Securities Regulatory Commission (CSRC) on November 7, 2025, due to suspected false reporting of financial data [1] - If the CSRC's subsequent administrative penalties confirm the violations, the company may face mandatory delisting under the Shenzhen Stock Exchange's rules for major violations [1]

Core Viewpoint - *ST Changyao has been under investigation by the China Securities Regulatory Commission (CSRC) for suspected false reporting of financial data, which could lead to a forced delisting if major violations are confirmed [2]. Financial Performance - As of December 31, 2024, *ST Changyao reported a negative net asset of 433 million yuan and an accumulated loss of 1.59 billion yuan [2]. - In the first three quarters of 2025, the company's revenue increased by 4.40% year-on-year to 105 million yuan, while the net profit attributable to shareholders decreased by 15.89% to -210 million yuan [2]. - The net profit excluding non-recurring items fell by 16.99% to -209 million yuan, with net assets further declining to -643 million yuan [2]. Stock Performance - As of November 7, *ST Changyao's stock price was 3.45 yuan per share, down 0.58%, with a total market capitalization of 1.209 billion yuan [2][3]. - The stock has shown a trading volume of 75,300 shares, with a turnover rate of 2.15% [3].

Core Points - Company received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected false financial reporting [1] - The investigation is related to the company's periodic reports and financial data [1] - If the investigation leads to a determination of significant violations, the company may face mandatory delisting due to serious misconduct [1]

Core Viewpoint - The company *ST长药 (300391.SZ) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected false reporting of financial data, which may lead to severe penalties and potential delisting from the Shenzhen Stock Exchange if found guilty [1] Summary by Relevant Sections - **Investigation Details** - The company was notified on November 7, 2025, about the investigation due to allegations of false financial reporting [1] - The CSRC's decision to initiate the investigation is based on relevant laws and regulations [1] - **Potential Consequences** - If the CSRC confirms the allegations and determines that they constitute a major violation under the revised Shenzhen Stock Exchange listing rules (2025), the company may face mandatory delisting [1]

Core Viewpoint - *ST Changyao (300391.SZ) has been notified by the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged false reporting of financial data, which may lead to significant penalties and potential delisting from the Shenzhen Stock Exchange if found guilty [1] Summary by Relevant Sections - **Investigation Details** - The company received a "Notice of Investigation" from the CSRC on November 7, 2025, due to suspected false records in periodic financial reports [1] - **Potential Consequences** - If the CSRC confirms the violations, the company may face administrative penalties that could trigger mandatory delisting under the revised Shenzhen Stock Exchange listing rules for the Growth Enterprise Market (2025) [1]

Core Viewpoint - The company, *ST Changyao, has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged false financial reporting, which could lead to significant legal consequences and potential delisting of its stock [1] Group 1 - The company received the "Notice of Investigation" from the CSRC on November 7, 2025 [1] - The investigation is due to allegations of false records in periodic financial reports [1] - If the investigation confirms major violations, the company may face mandatory delisting due to serious legal infractions [1]